Puncture Test for Elastomeric Closure: Ensuring Quality of Ampoule Seals per ISO 8871-5 and USP 381

Maintaining the integrity of elastomeric closures is critical in pharmaceutical packaging. The Испытание на прокол эластомерного затвора is a fundamental quality control procedure that ensures rubber stoppers used in ampoules and vials meet stringent safety and performance criteria. From protecting medication sterility to enabling safe needle penetration, the reliability of these closures directly impacts patient outcomes.

Importance of Puncture Testing in Pharmaceutical Packaging

In pharmaceutical applications, elastomeric closures must withstand repeated needle punctures without compromising vial integrity. The Испытание на прокол эластомерного затвора evaluates the force required for a hypodermic needle to penetrate a closure. This is not just a mechanical property test; it’s a safeguard against contamination, leakage, and inconsistent dosing.

According to ISO 8871-5, which governs the functional requirements of elastomeric parts used in parenterals, and USP 381, closures must demonstrate adequate penetrability, minimal fragmentation, and strong self-sealing properties. These criteria are vital, especially for multi-dose ampoule elastomeric closure tests, where closures may be pierced multiple times.

Ampoule Elastomeric Closure Test Procedures (ISO 8871-5, USP 381)

Penetrability Test (Annex A of ISO 8871-5)
The first step in assessing an elastomeric closure’s functionality is measuring its penetrability—the force required for a standard hypodermic needle to fully pierce the stopper. This test typically uses a needle with a 0.8 mm external diameter and a bevel angle of 11°, as specified in ISO 7864.

• Test Setup: Vials are sealed with elastomeric closures and pierced using a force gauge-equipped testing machine.
• Acceptance Criteria: The force must not exceed 10 N, ensuring easy needle insertion without compromising the closure or causing discomfort during injections.

Fragmentation Test (Annex B)
Repeated needle insertions can create particles of rubber that contaminate the contents. This test checks whether visible fragments appear after 48 piercings.

• Limit: A maximum of 5 visible fragments is allowed, preserving the purity of pharmaceutical formulations.

Self-Sealing and Aqueous Solution Tightness (Annex C)
Closures must reseal after needle withdrawal and prevent leakage. In this test, closures are punctured 10 times, submerged in methylene blue dye, and subjected to vacuum conditions.

• Result Criterion: No vial should show any trace of dye inside, proving the closure’s sealing integrity.

How the Cell Instruments Needle Puncture Tester Supports Compliance

Cell Instruments offers an advanced Needle Puncture Tester tailored to meet ISO 8871-5 and USP 381 specifications. Designed with PLC control, a 7-inch HMI touch screen, and variable-speed drive, this tester ensures precision and repeatability.

Key Features Include:

• High-accuracy force measurement up to 10 N with ±0.25 N tolerance
• Flexible sample holders for closures of various sizes
• Supports different types of hypodermic needles
• Automated return and micro-printer for fast reporting
• Safety measures like overload protection and position sensors

These features make the tester suitable for R&D, quality control labs, and production line validation.

Why Puncture Test Results Matter for Your Business

In an era where compliance with ISO 8871-5 and USP 381 is non-negotiable, investing in reliable testing technology is a business-critical decision. Improperly tested closures can result in:

• Regulatory failures
• Product recalls
• Compromised patient safety
• Damaged brand reputation

By integrating rigorous puncture and sealing tests into your QC pipeline, you not only meet global standards but also enhance drug delivery system performance and patient satisfaction.

Conclusion: Strengthening Packaging Integrity with Functional Testing